News from the healthcare data industry
BEIJING, June 1, 2023 /PRNewswire/ — EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical...
HAIKOU, China, Dec. 9, 2022 /PRNewswire/ — On December 8, the first Boao International Conference on Real World Studies of Medical Products was held in Hainan Province, with the theme of “Real World Data Studies...
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines August 15, 2022 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS...
May 25, 2022 Bruce Liu, Justinian Liu, Selene Peng, Wolfgang Liang Its use enables key processes such as early access, regulatory approval, and reimbursement listing. Real world evidence (RWE) is playing an increasingly important...
LinkDoc Technology Limited, a Chinese medical big data company, announced on Monday that it has withdrawn its application for a public listing in the United States. In June 2021, LinkDoc...
SHANGHAI, March 14, 2022 /PRNewswire/ — Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases, announced that the...
Background: Abiraterone and enzalutamide are widely used as first-line treatment for metastatic castration-resistant prostate cancer (mCRPC); however, their efficacy in mCRPC has been inconsistently demonstrated in other outcome studies from real-world...
Pharmaceutical giant Johnson & Johnson has strengthened cooperation with Shanghai to further drive local innovative health-care solutions. Janssen (China) Research and Development Center of Johnson & Johnson (China) Investment Co...
Highlights Many new data sources have emerged in response to the increasing demand for real-world evidence to support healthcare decisionmaking in China. Nevertheless, public information regarding these data sources is...
Survey by BioCentury and Happy Life Technologies finds high hopes but delayed expectations for RWE to deliver value in China R&D BY LAUREN MARTZ, SENIOR EDITOR AND RIMMEL SHEKHA, BIOPHARMA ANALYSTNovember...